HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-FEB-19 6NW2 TITLE STRUCTURE OF HUMAN RIPK1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CELL DEATH PROTEIN RIP,RECEPTOR-INTERACTING PROTEIN 1,RIP-1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RIPK1, RIP, RIP1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS RIP1, KINASE, RIP, RIP1K RIPK1, IMMUNE SYSTEM, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.FONG,P.J.LUPARDUS REVDAT 3 13-MAR-24 6NW2 1 REMARK REVDAT 2 15-MAY-19 6NW2 1 JRNL REVDAT 1 01-MAY-19 6NW2 0 JRNL AUTH G.L.HAMILTON,H.CHEN,G.DESHMUKH,C.EIGENBROT,R.FONG,A.JOHNSON, JRNL AUTH 2 P.B.KOHLI,P.J.LUPARDUS,B.M.LIEDERER,S.RAMASWAMY,H.WANG, JRNL AUTH 3 J.WANG,Z.XU,Y.ZHU,D.VUCIC,S.PATEL JRNL TITL POTENT AND SELECTIVE INHIBITORS OF RECEPTOR-INTERACTING JRNL TITL 2 PROTEIN KINASE 1 THAT LACK AN AROMATIC BACK POCKET GROUP. JRNL REF BIOORG.MED.CHEM.LETT. V. 29 1497 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 31000154 JRNL DOI 10.1016/J.BMCL.2019.04.014 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1-2155_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.09 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 38458 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.650 REMARK 3 FREE R VALUE TEST SET COUNT : 2557 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.0962 - 5.2390 1.00 2148 169 0.1956 0.2267 REMARK 3 2 5.2390 - 4.1593 1.00 2044 146 0.1652 0.2235 REMARK 3 3 4.1593 - 3.6338 1.00 2051 144 0.1852 0.2041 REMARK 3 4 3.6338 - 3.3016 1.00 2000 139 0.1991 0.2516 REMARK 3 5 3.3016 - 3.0651 1.00 1989 148 0.2157 0.2788 REMARK 3 6 3.0651 - 2.8844 1.00 1993 146 0.2346 0.3013 REMARK 3 7 2.8844 - 2.7399 1.00 1998 150 0.2244 0.2785 REMARK 3 8 2.7399 - 2.6207 1.00 1982 134 0.2167 0.3000 REMARK 3 9 2.6207 - 2.5198 1.00 1987 141 0.2178 0.2420 REMARK 3 10 2.5198 - 2.4329 1.00 1954 158 0.2055 0.2925 REMARK 3 11 2.4329 - 2.3568 1.00 1994 135 0.2097 0.2611 REMARK 3 12 2.3568 - 2.2894 1.00 1940 139 0.2224 0.3341 REMARK 3 13 2.2894 - 2.2292 0.99 1970 143 0.3167 0.4030 REMARK 3 14 2.2292 - 2.1748 1.00 1983 123 0.2810 0.4073 REMARK 3 15 2.1748 - 2.1253 1.00 1986 124 0.2312 0.2787 REMARK 3 16 2.1253 - 2.0801 1.00 1942 138 0.2351 0.2760 REMARK 3 17 2.0801 - 2.0385 1.00 1998 138 0.2412 0.3256 REMARK 3 18 2.0385 - 2.0000 1.00 1942 142 0.2657 0.3440 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4176 REMARK 3 ANGLE : 0.913 5634 REMARK 3 CHIRALITY : 0.056 626 REMARK 3 PLANARITY : 0.006 705 REMARK 3 DIHEDRAL : 14.331 2527 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NW2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-19. REMARK 100 THE DEPOSITION ID IS D_1000239558. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38557 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 48.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 0.86800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS TRIS PROPANE PH 6.5, 0.2M REMARK 280 SODIUM IODIDE, 20% PEG3350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.93100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.64250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.32200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.64250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.93100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.32200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 GLY A -8 REMARK 465 GLU A -7 REMARK 465 ASN A -6 REMARK 465 LEU A -5 REMARK 465 TYR A -4 REMARK 465 PHE A -3 REMARK 465 GLN A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 PRO A 3 REMARK 465 ASP A 4 REMARK 465 MET A 5 REMARK 465 SER A 6 REMARK 465 LEU A 7 REMARK 465 GLU A 19 REMARK 465 SER A 20 REMARK 465 ALA A 21 REMARK 465 GLU A 22 REMARK 465 LEU A 23 REMARK 465 ASP A 24 REMARK 465 SER A 25 REMARK 465 GLY A 26 REMARK 465 GLY A 27 REMARK 465 PHE A 28 REMARK 465 GLY A 29 REMARK 465 ARG A 177 REMARK 465 GLU A 178 REMARK 465 VAL A 179 REMARK 465 ASP A 180 REMARK 465 GLY A 181 REMARK 465 THR A 182 REMARK 465 ALA A 183 REMARK 465 LYS A 184 REMARK 465 LYS A 185 REMARK 465 ASN A 186 REMARK 465 GLY A 187 REMARK 465 GLY A 188 REMARK 465 ASN A 199 REMARK 465 ASP A 200 REMARK 465 VAL A 201 REMARK 465 ASN A 202 REMARK 465 MET B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 GLY B -8 REMARK 465 GLU B -7 REMARK 465 ASN B -6 REMARK 465 LEU B -5 REMARK 465 TYR B -4 REMARK 465 PHE B -3 REMARK 465 GLN B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 PRO B 3 REMARK 465 ASP B 4 REMARK 465 MET B 5 REMARK 465 SER B 6 REMARK 465 LEU B 7 REMARK 465 ASN B 8 REMARK 465 VAL B 9 REMARK 465 ILE B 10 REMARK 465 GLU B 19 REMARK 465 SER B 20 REMARK 465 ALA B 21 REMARK 465 GLU B 22 REMARK 465 LEU B 23 REMARK 465 ASP B 24 REMARK 465 SER B 25 REMARK 465 GLY B 26 REMARK 465 GLY B 27 REMARK 465 PHE B 28 REMARK 465 TYR B 48 REMARK 465 LYS B 49 REMARK 465 GLY B 50 REMARK 465 PRO B 51 REMARK 465 ASN B 52 REMARK 465 GLU B 84 REMARK 465 GLU B 85 REMARK 465 ASN B 170 REMARK 465 GLU B 171 REMARK 465 GLU B 172 REMARK 465 HIS B 173 REMARK 465 ASN B 174 REMARK 465 GLU B 175 REMARK 465 LEU B 176 REMARK 465 ARG B 177 REMARK 465 GLU B 178 REMARK 465 VAL B 179 REMARK 465 ASP B 180 REMARK 465 GLY B 181 REMARK 465 THR B 182 REMARK 465 ALA B 183 REMARK 465 LYS B 184 REMARK 465 LYS B 185 REMARK 465 ASN B 186 REMARK 465 GLY B 187 REMARK 465 ASN B 230 REMARK 465 ALA B 231 REMARK 465 ILE B 232 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 GLU A 55 CG CD OE1 OE2 REMARK 470 LEU A 176 CG CD1 CD2 REMARK 470 LYS B 11 CG CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 470 LEU B 18 CG CD1 CD2 REMARK 470 LYS B 30 CG CD CE NZ REMARK 470 ARG B 37 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 55 CG CD OE1 OE2 REMARK 470 HIS B 56 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 58 CG CD OE1 OE2 REMARK 470 LYS B 87 CG CD CE NZ REMARK 470 GLU B 283 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 52 38.83 -85.45 REMARK 500 CYS A 53 -0.50 -52.87 REMARK 500 GLU A 107 -72.75 -53.14 REMARK 500 LYS A 137 -14.78 78.22 REMARK 500 HIS A 173 41.28 -83.69 REMARK 500 ARG B 37 3.31 -60.59 REMARK 500 THR B 38 -9.46 -146.78 REMARK 500 GLU B 55 49.34 -92.88 REMARK 500 HIS B 56 25.19 -141.15 REMARK 500 LYS B 137 -16.37 81.67 REMARK 500 ASP B 138 47.31 -141.36 REMARK 500 ASP B 200 83.69 -158.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L4Y A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L4Y B 301 DBREF 6NW2 A 1 294 UNP Q13546 RIPK1_HUMAN 1 294 DBREF 6NW2 B 1 294 UNP Q13546 RIPK1_HUMAN 1 294 SEQADV 6NW2 MET A -15 UNP Q13546 INITIATING METHIONINE SEQADV 6NW2 HIS A -14 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS A -13 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS A -12 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS A -11 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS A -10 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS A -9 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLY A -8 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLU A -7 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 ASN A -6 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 LEU A -5 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 TYR A -4 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 PHE A -3 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLN A -2 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLY A -1 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 SER A 0 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 ALA A 34 UNP Q13546 CYS 34 CONFLICT SEQADV 6NW2 ALA A 127 UNP Q13546 CYS 127 CONFLICT SEQADV 6NW2 ALA A 233 UNP Q13546 CYS 233 CONFLICT SEQADV 6NW2 ALA A 240 UNP Q13546 CYS 240 CONFLICT SEQADV 6NW2 MET B -15 UNP Q13546 INITIATING METHIONINE SEQADV 6NW2 HIS B -14 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS B -13 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS B -12 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS B -11 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS B -10 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 HIS B -9 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLY B -8 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLU B -7 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 ASN B -6 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 LEU B -5 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 TYR B -4 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 PHE B -3 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLN B -2 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 GLY B -1 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 SER B 0 UNP Q13546 EXPRESSION TAG SEQADV 6NW2 ALA B 34 UNP Q13546 CYS 34 CONFLICT SEQADV 6NW2 ALA B 127 UNP Q13546 CYS 127 CONFLICT SEQADV 6NW2 ALA B 233 UNP Q13546 CYS 233 CONFLICT SEQADV 6NW2 ALA B 240 UNP Q13546 CYS 240 CONFLICT SEQRES 1 A 310 MET HIS HIS HIS HIS HIS HIS GLY GLU ASN LEU TYR PHE SEQRES 2 A 310 GLN GLY SER MET GLN PRO ASP MET SER LEU ASN VAL ILE SEQRES 3 A 310 LYS MET LYS SER SER ASP PHE LEU GLU SER ALA GLU LEU SEQRES 4 A 310 ASP SER GLY GLY PHE GLY LYS VAL SER LEU ALA PHE HIS SEQRES 5 A 310 ARG THR GLN GLY LEU MET ILE MET LYS THR VAL TYR LYS SEQRES 6 A 310 GLY PRO ASN CYS ILE GLU HIS ASN GLU ALA LEU LEU GLU SEQRES 7 A 310 GLU ALA LYS MET MET ASN ARG LEU ARG HIS SER ARG VAL SEQRES 8 A 310 VAL LYS LEU LEU GLY VAL ILE ILE GLU GLU GLY LYS TYR SEQRES 9 A 310 SER LEU VAL MET GLU TYR MET GLU LYS GLY ASN LEU MET SEQRES 10 A 310 HIS VAL LEU LYS ALA GLU MET SER THR PRO LEU SER VAL SEQRES 11 A 310 LYS GLY ARG ILE ILE LEU GLU ILE ILE GLU GLY MET ALA SEQRES 12 A 310 TYR LEU HIS GLY LYS GLY VAL ILE HIS LYS ASP LEU LYS SEQRES 13 A 310 PRO GLU ASN ILE LEU VAL ASP ASN ASP PHE HIS ILE LYS SEQRES 14 A 310 ILE ALA ASP LEU GLY LEU ALA SER PHE LYS MET TRP SER SEQRES 15 A 310 LYS LEU ASN ASN GLU GLU HIS ASN GLU LEU ARG GLU VAL SEQRES 16 A 310 ASP GLY THR ALA LYS LYS ASN GLY GLY THR LEU TYR TYR SEQRES 17 A 310 MET ALA PRO GLU HIS LEU ASN ASP VAL ASN ALA LYS PRO SEQRES 18 A 310 THR GLU LYS SER ASP VAL TYR SER PHE ALA VAL VAL LEU SEQRES 19 A 310 TRP ALA ILE PHE ALA ASN LYS GLU PRO TYR GLU ASN ALA SEQRES 20 A 310 ILE ALA GLU GLN GLN LEU ILE MET ALA ILE LYS SER GLY SEQRES 21 A 310 ASN ARG PRO ASP VAL ASP ASP ILE THR GLU TYR CYS PRO SEQRES 22 A 310 ARG GLU ILE ILE SER LEU MET LYS LEU CYS TRP GLU ALA SEQRES 23 A 310 ASN PRO GLU ALA ARG PRO THR PHE PRO GLY ILE GLU GLU SEQRES 24 A 310 LYS PHE ARG PRO PHE TYR LEU SER GLN LEU GLU SEQRES 1 B 310 MET HIS HIS HIS HIS HIS HIS GLY GLU ASN LEU TYR PHE SEQRES 2 B 310 GLN GLY SER MET GLN PRO ASP MET SER LEU ASN VAL ILE SEQRES 3 B 310 LYS MET LYS SER SER ASP PHE LEU GLU SER ALA GLU LEU SEQRES 4 B 310 ASP SER GLY GLY PHE GLY LYS VAL SER LEU ALA PHE HIS SEQRES 5 B 310 ARG THR GLN GLY LEU MET ILE MET LYS THR VAL TYR LYS SEQRES 6 B 310 GLY PRO ASN CYS ILE GLU HIS ASN GLU ALA LEU LEU GLU SEQRES 7 B 310 GLU ALA LYS MET MET ASN ARG LEU ARG HIS SER ARG VAL SEQRES 8 B 310 VAL LYS LEU LEU GLY VAL ILE ILE GLU GLU GLY LYS TYR SEQRES 9 B 310 SER LEU VAL MET GLU TYR MET GLU LYS GLY ASN LEU MET SEQRES 10 B 310 HIS VAL LEU LYS ALA GLU MET SER THR PRO LEU SER VAL SEQRES 11 B 310 LYS GLY ARG ILE ILE LEU GLU ILE ILE GLU GLY MET ALA SEQRES 12 B 310 TYR LEU HIS GLY LYS GLY VAL ILE HIS LYS ASP LEU LYS SEQRES 13 B 310 PRO GLU ASN ILE LEU VAL ASP ASN ASP PHE HIS ILE LYS SEQRES 14 B 310 ILE ALA ASP LEU GLY LEU ALA SER PHE LYS MET TRP SER SEQRES 15 B 310 LYS LEU ASN ASN GLU GLU HIS ASN GLU LEU ARG GLU VAL SEQRES 16 B 310 ASP GLY THR ALA LYS LYS ASN GLY GLY THR LEU TYR TYR SEQRES 17 B 310 MET ALA PRO GLU HIS LEU ASN ASP VAL ASN ALA LYS PRO SEQRES 18 B 310 THR GLU LYS SER ASP VAL TYR SER PHE ALA VAL VAL LEU SEQRES 19 B 310 TRP ALA ILE PHE ALA ASN LYS GLU PRO TYR GLU ASN ALA SEQRES 20 B 310 ILE ALA GLU GLN GLN LEU ILE MET ALA ILE LYS SER GLY SEQRES 21 B 310 ASN ARG PRO ASP VAL ASP ASP ILE THR GLU TYR CYS PRO SEQRES 22 B 310 ARG GLU ILE ILE SER LEU MET LYS LEU CYS TRP GLU ALA SEQRES 23 B 310 ASN PRO GLU ALA ARG PRO THR PHE PRO GLY ILE GLU GLU SEQRES 24 B 310 LYS PHE ARG PRO PHE TYR LEU SER GLN LEU GLU HET L4Y A 301 26 HET L4Y B 301 26 HETNAM L4Y (5R)-5-METHYL-N-[(3S)-5-METHYL-4-OXO-2,3,4,5- HETNAM 2 L4Y TETRAHYDRO-1,5-BENZOXAZEPIN-3-YL]-4,5,6,7-TETRAHYDRO- HETNAM 3 L4Y 2H-INDAZOLE-3-CARBOXAMIDE FORMUL 3 L4Y 2(C19 H22 N4 O3) FORMUL 5 HOH *201(H2 O) HELIX 1 AA1 LYS A 13 PHE A 17 5 5 HELIX 2 AA2 HIS A 56 ARG A 69 1 14 HELIX 3 AA3 ASN A 99 LYS A 105 1 7 HELIX 4 AA4 PRO A 111 LYS A 132 1 22 HELIX 5 AA5 LYS A 140 GLU A 142 5 3 HELIX 6 AA6 PHE A 162 ASN A 170 1 9 HELIX 7 AA7 THR A 189 MET A 193 5 5 HELIX 8 AA8 ALA A 194 LEU A 198 5 5 HELIX 9 AA9 THR A 206 ASN A 224 1 19 HELIX 10 AB1 ALA A 233 SER A 243 1 11 HELIX 11 AB2 ASP A 248 ILE A 252 5 5 HELIX 12 AB3 PRO A 257 TRP A 268 1 12 HELIX 13 AB4 ASN A 271 ARG A 275 5 5 HELIX 14 AB5 THR A 277 LEU A 293 1 17 HELIX 15 AB6 LYS B 13 PHE B 17 5 5 HELIX 16 AB7 HIS B 56 ARG B 69 1 14 HELIX 17 AB8 ASN B 99 LYS B 105 1 7 HELIX 18 AB9 PRO B 111 LYS B 132 1 22 HELIX 19 AC1 LYS B 140 GLU B 142 5 3 HELIX 20 AC2 PHE B 162 ASN B 169 1 8 HELIX 21 AC3 ALA B 194 LEU B 198 5 5 HELIX 22 AC4 THR B 206 ASN B 224 1 19 HELIX 23 AC5 GLU B 234 SER B 243 1 10 HELIX 24 AC6 ASP B 248 ILE B 252 5 5 HELIX 25 AC7 PRO B 257 TRP B 268 1 12 HELIX 26 AC8 ASN B 271 ARG B 275 5 5 HELIX 27 AC9 THR B 277 LEU B 293 1 17 SHEET 1 AA1 5 ILE A 10 LYS A 11 0 SHEET 2 AA1 5 LEU A 78 GLU A 84 1 O VAL A 81 N ILE A 10 SHEET 3 AA1 5 LYS A 87 MET A 92 -1 O SER A 89 N ILE A 82 SHEET 4 AA1 5 GLY A 40 LYS A 49 -1 N LYS A 45 O LEU A 90 SHEET 5 AA1 5 VAL A 31 HIS A 36 -1 N HIS A 36 O GLY A 40 SHEET 1 AA2 2 ILE A 144 VAL A 146 0 SHEET 2 AA2 2 ILE A 152 ILE A 154 -1 O LYS A 153 N LEU A 145 SHEET 1 AA3 4 SER B 32 HIS B 36 0 SHEET 2 AA3 4 GLY B 40 THR B 46 -1 O MET B 44 N SER B 32 SHEET 3 AA3 4 SER B 89 GLU B 93 -1 O MET B 92 N ILE B 43 SHEET 4 AA3 4 LEU B 78 ILE B 82 -1 N ILE B 82 O SER B 89 SHEET 1 AA4 2 ILE B 144 VAL B 146 0 SHEET 2 AA4 2 ILE B 152 ILE B 154 -1 O LYS B 153 N LEU B 145 SITE 1 AC1 12 ILE A 43 LYS A 45 MET A 67 VAL A 75 SITE 2 AC1 12 VAL A 76 LEU A 78 LEU A 90 MET A 92 SITE 3 AC1 12 ASP A 156 LEU A 157 LEU A 159 HOH A 473 SITE 1 AC2 14 VAL B 31 ILE B 43 LYS B 45 MET B 67 SITE 2 AC2 14 VAL B 75 VAL B 76 LEU B 78 LEU B 90 SITE 3 AC2 14 MET B 92 ILE B 154 ASP B 156 LEU B 157 SITE 4 AC2 14 LEU B 159 HOH B 424 CRYST1 45.862 96.644 125.285 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021805 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010347 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007982 0.00000